Att 2_60d FRN

Att 2_60d FRN.pdf

CDC and ATSDR Health Message Testing System

Att 2_60d FRN

OMB: 0920-0572

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0572 can be found here:

Document [pdf]

Download: pdf | pdf

sroberts on DSK5SPTVN1PROD with NOTICES

Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Notices
Coordinator for Health Information
Technology;
(2) Shall have complied with all the
requirements under this section;
(3) In the case of a private entity, shall
be incorporated in and maintain a
primary place of business in the United
States, and in the case of an individual,
whether participating singly or in a
group, shall be a citizen or permanent
resident of the United States; and
(4) May not be a Federal entity or
Federal employee acting within the
scope of their employment.
An individual or entity shall not be
deemed ineligible because the
individual or entity used Federal
facilities or consulted with Federal
employees during a competition if the
facilities and employees are made
available to all individuals and entities
participating in the competition on an
equitable basis.
Registered participants shall be
required to agree to assume any and all
risks and waive claims against the
Federal Government and its related
entities, except in the case of willful
misconduct, for any injury, death,
damage, or loss of property, revenue, or
profits, whether direct, indirect, or
consequential, arising from their
participation in a competition, whether
the injury, death, damage, or loss arises
through negligence or otherwise.
Participants shall be required to
obtain liability insurance or
demonstrate financial responsibility, in
amounts determined by the head of the
Office of the National Coordinator for
Health Information Technology, for
claims by—
(1) A third party for death, bodily
injury, or property damage, or loss
resulting from an activity carried out in
connection with participation in a
competition, with the Federal
Government named as an additional
insured under the registered
participant’s insurance policy and
registered participants agreeing to
indemnify the Federal Government
against third party claims for damages
arising from or related to competition
activities; and
(2) the Federal Government for
damage or loss to Government property
resulting from such an activity.
Participants must be teams of at least
two people.
All participants are required to
provide written consent to the rules
upon or before submitting an entry.
DATES:
Phase I
• Submission Period Begins:
12:01am, EDT, July 15th, 2011.

VerDate Mar<15>2010

16:12 Jul 25, 2011

Jkt 223001

• Submission Period for Initial
Entries Ends: 11:59 pm, EDT, August
26th, 2011.
Phase II:
• Final Submission Period Begins:
12:01am, E.D.T., October 3rd, 2011.
• Final Submission Period Ends:
11:59pm, E.S.T., November 18th, 2011.
Registration Process for Participants
To register for this challenge
participants should:
• Access the http://
www.challenge.gov Web site and search
for the ‘‘Using Public Data for Cancer
Prevention and Control: From
Innovation to Impact Challenge’’.
• Access the ONC Investing in
Innovation (i2) Challenge Web site at:
Æ http://www.health2challenge.org/
category/onc/.
Æ A registration link for the challenge
can be found on the landing page under
the challenge description.
Amount of the Prize
Phase I
• Four semi-finalists will receive
prizes of $10,000 each.
Phase II
• Two finalist teams will receive
awards of $20,000 each.
Awards may be subject to Federal
income taxes and HHS will comply with
IRS withholding and reporting
requirements, where applicable.
Basis Upon Which Winner Will Be
Selected
The judging panel will make
selections based upon the following
criteria:
1. Impact on cancer prevention and
control.
2. Use of cancer-related data.
3. Integration with existing health
records.
4. Innovation.
5. Usability.
Additional Information
Ownership of intellectual property is
determined by the following:
• Each entrant retains title and full
ownership in and to their submission.
Entrants expressly reserve all
intellectual property rights not
expressly granted under the challenge
agreement.
• By participating in the challenge,
each entrant hereby irrevocably grants
to Sponsor and Administrator a limited,
non-exclusive, royalty free, worldwide,
license and right to reproduce,
publically perform, publically display,
and use the Submission to the extent
necessary to administer the challenge,

PO 00000

Frm 00020

Fmt 4703

Sfmt 4703

44589

and to publically perform and
publically display the Submission,
including, without limitation, for
advertising and promotional purposes
relating to the challenge.
Dated: July 18, 2011.
Farzad Mostashari,
National Coordinator for Health Information
Technology.
[FR Doc. 2011–18728 Filed 7–25–11; 8:45 am]
BILLING CODE 4150–45–

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[[60Day–11–0572]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to, Daniel Holcomb,
CDC Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Health Message Testing System,
(0920–0572, exp. 11/30/2011)—
Revision—Office of the Associate
Director for Communication, Centers for
Disease Control and Prevention (CDC).

E:\FR\FM\26JYN1.SGM

26JYN1

44590

Federal Register / Vol. 76, No. 143 / Tuesday, July 26, 2011 / Notices

Background and Brief Description
Before CDC disseminates a health
message to the public, the message
always undergoes scientific review.
However, even though the message is
based on sound scientific content, there
is no guarantee that the public will
understand a health message or that the
message will move people to take
recommended action. Communication
theorists and researchers agree that for
health messages to be as clear and
influential as possible, target audience
members or representatives must be
involved in developing the messages
and provisional versions of the
messages must be tested with members
of the target audience.
However, increasingly there are
circumstances when CDC must move
swiftly to protect life, prevent disease,
or calm public anxiety. Health message
testing is even more important in these
instances, because of the critical nature
of the information need.
CDC receives a mandate from
Congress with a tight deadline for
communicating with the public about a
specific topic. For example, Congress
gave CDC 120 days to develop and test
messages for a public information
campaign about Helicobacter pylori, a
bacterium that can cause stomach ulcers
and increase cancer risk if an infected
individual is not treated with
antibiotics.
In the interest of timely health
message dissemination, many programs

forgo the important step of testing
messages on dimensions such as clarity,
salience, appeal, and persuasiveness
(i.e., the ability to influence behavioral
intention). Skipping this step avoids the
delay involved in the standard OMB
review process, but at a high potential
cost. Untested messages can waste
communication resources and
opportunities because the messages can
be perceived as unclear or irrelevant.
Untested messages can also have
unintended consequences, such as
jeopardizing the credibility of Federal
health officials.
The Health Message Testing System
(HMTS), a generic information
collection, will enable programs across
CDC to collect the information they
require in a timely manner to:
• Ensure quality and prevent waste in
the dissemination of health information
by CDC to the public.
• Refine message concepts and to test
draft materials for clarity, salience,
appeal, and persuasiveness to target
audiences.
• Guide the action of health
communication officials who are
responding to health emergencies,
Congressionally-mandated campaigns
with short timeframes, media-generated
public concern, time-limited
communication opportunities, trends,
and the need to refresh materials or
dissemination strategies in an ongoing
campaign.

Each testing instrument will be based on
specific health issues or topics.
Although it is not possible to develop
one instrument for use in all instances,
the same kinds of questions are asked in
most message testing. This package
includes generic questions and formats
that can be used to develop health
message testing data collection
instruments. These include a list of
screening questions, comprised of
demographic and introductory
questions, along with other questions
that can be used to create a mix of
relevant questions for each proposed
message testing data collection method.
However, programs may request to use
additional questions if needed.
Message testing questions will focus
on issues such as comprehension,
impressions, personal relevance,
content and wording, efficacy of
response, channels, and spokesperson/
sponsor. Such information will enable
message developers to enhance the
effectiveness of messages for intended
audiences.
Data collection methods proposed for
HMTS include intercept interviews,
telephone interviews, focus groups,
online surveys, and cognitive
interviews. In almost all instances, data
will be collected by outside
organizations under contract with CDC.
There is no cost to the respondents
other than their time.

TABLE A12A—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
per method

Data collection methods

Average
burden per
response
(in hours)

Total burden
hours

Central Location Intercept Interviews, Telephone Interviews, Individual Indepth Interview (Cognitive Interviews), Focus Group Screenings, Focus
Groups, Online Surveys ...............................................................................

18,525

8/60

2,470

Total ..........................................................................................................

18,525

........................

2,470

Dated: July 19, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–18807 Filed 7–25–11; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–11–11FK]

BILLING CODE 4163–18–P

Agency Forms Undergoing Paperwork
Reduction Act Review
sroberts on DSK5SPTVN1PROD with NOTICES

Number of
responses per
respondent

The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these